First systematic integration: This work presents the first comprehensive outline of the synergistic potential of nanoparticle-enabled ferroptosis–immunotherapy strategies against malignancies, moving ...

Expert Rev Clin Immunol. 2012;8(6):557-564. The dose-escalation procedure was shown to be safe, eliciting only mild to moderate symptoms. During the treatment phase, local symptoms were the most ...

Do Local Reactions Predict Local Reactions With the Next Injection? Local reactions from immunotherapy are fairly common. They occur with a frequency of 26–82% among patients receiving AIT and in ...

Step 1, data collection: immunogenomics (genomics/transcriptomics), radiomics, and digital pathology data from the real world are appropriately collected and stored. Step 2, data processing: data from ...

According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at ...

A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies works together to recruit new cancer-fighting T cells with every infusion. Findings ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy without increasing the risk of severe lung inflammation (pneumonitis). This is ...

T, an in-situ platform combination immunotherapy optimized for solid tumor cancers, has announced the appointment of Stephen ...